GoodRx Holdings, Inc. GDRX Debt Issuance Cost Amortization
Debt Issuance Cost Amortization at other companies
Other financials
Where this comes from
Reported directly by GoodRx Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about GoodRx Holdings, Inc.'s debt issuance cost amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GoodRx Holdings, Inc.'s debt issuance cost amortization?
- GoodRx Holdings, Inc. (GDRX) reported debt issuance cost amortization of $462K in Q1 2026.
- How has GoodRx Holdings, Inc.'s debt issuance cost amortization changed year-over-year?
- GoodRx Holdings, Inc.'s debt issuance cost amortization increased by 7.4% year-over-year, from $430K to $462K.
- What is the long-term trend for GoodRx Holdings, Inc.'s debt issuance cost amortization?
- Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s debt issuance cost amortization has grown at a -15.4% compound annual growth rate (CAGR), from $3.45M to $1.77M.
- What does debt issuance cost amortization mean?
- Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).